Is Trupanion, Inc. (TRUP) A Good Stock To Buy Now?
This article summarizes a bullish thesis on Trupanion, Inc. (TRUP), highlighting its subscription-driven pet insurance model, disciplined capital deployment, and potential for long-term intrinsic value growth despite recent margin compression. The company's competitive moat is attributed to its point-of-care distribution and strong retention, with management guiding for 13-15% subscription growth and about 15% margins by FY2026. The article suggests TRUP is an underappreciated compounder with improving economics.
MAY 1·The Motley Fool▲
Trupanion (TRUP) Q1 2026 Earnings Transcript
Trupanion reported strong Q1 2026 results, with adjusted operating income up 29% year over year to $40.2 million and total revenue increasing 12% to $384 million. The company is focusing on Adjusted Operating Income (AOI) as its primary financial metric, attributing significant growth to it, and plans to broaden product offerings and launch a new digital-first solution to attract a wider customer base. Trupanion maintains its full-year guidance and remains committed to strategic investments and operational efficiency, including increased claims automation.
APR 30·Stock Titan▼
Trupanion (NASDAQ: TRUP) COO sells 431 shares in planned trade
Trupanion's Chief Operating Officer, John R. Gallagher, sold 431 shares of common stock at $27.47 per share. This transaction was conducted under a pre-established Rule 10b5-1 trading plan for financial diversification, meaning the timing was not at his discretion. Following the sale, Gallagher continues to directly hold 31,526 shares of Trupanion stock.
